Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(1):91-6
Article Links
Leflunomide Induced Atypical DRESS: A Case Report and Literature Review
Maryam Fatima1, Salwa Sahar Azimi2, Soumya Ashwini1, Madhuri H Radhakrishna3
Authors Information
1Clinical Pharmacist-AIG Hospitals, India
2Clinical Pharmacist intern, Department of Pharmacy Practice, G. Pulla Reddy College of Pharmacy, India
3Consultant Rheumatologist-AIG Hospitals, India
Keywords: DRESS, life-threatening, drug-induced, herpes viruses, Spanish guidelines, national guidelines, leflunomide, antirheumatic drug
References
  1. Parajuli S, Chaudhary D, Pandey S, Baral S, Pokhrel DB.  Leflunomide Induced DRESS Syndrome: A Case Report. NJDVL 2012;10(1):46-8. https://doi.org/10.3126/njdvl.v10i1.6423.
  2. Sasi S, Altarawneh H, Petkar MA, Nair AP. Drug Reaction with Eosinophilia and Systemic Symptoms Secondary to Naproxen: A Case Report and Literature Review. Case Rep Acute Med 2020;3:63-72. doi: 10.1159/000509712.
  3. Shanoj K C, Joseph S, Shenoy P. Drug reaction with eosinophilia and systemic symptoms syndrome. Indian J Rheumatol 2019;14, Suppl S1:59-66
  4. Shiohara T, Kano Y, Hirahara K, Aoyama Y. Prediction and management of drug reaction with eosinophilia and systemic symptoms (dress). Expert Opin Drug Metab Toxicol 2017;13(7):701-4. https://doi.org/10.1080/17425255.2017.1297422.
  5. Tan A, Stone BM. A female with rash and facial swelling. JETS 2010;3(2):187-8. https://doi.org/10.4103/0974-2700.62121
  6. Cho YT, Yang CW, Chu C Y. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Int. J Mol Sci 2017;18(6):1243. https://doi.org/10.3390/ijms18061243.
  7. Garuzi M, Thomazi R, Jacinto AF. DRESS syndrome in the aged: a differential diagnosis to be considered. Geriatr Gerontol Aging 2017;11:150-3.
  8. Parajuli S, Chaudhary D, Pandey S, Baral S, Pokhrel DB. Leflunomide Induced DRESS Syndrome: A Case Report. NJDVL 2012;10(1):46-8. https://doi.org/10.3126/njdvl.v10i1.6423.
  9. Scrace B, Fityan A, Bigham C. Drug reactions with eosinophilia and systemic symptoms. BJA Educ 2020;20(2):65-71. https://doi.org/10.1016/j.bjae.2019.11.0019.
  10. Shanoj KC, Joseph S, Shenoy P. Drug reaction with eosinophilia and systemic symptoms syndrome. Indian J Rheumatol 2019;14:S59-66.
  11. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206(4):353-6. doi: 10.1159/000069956. PMID: 12771485.
  12. Hellman C, Lonnkvist K, Hedlin G, Hallden G, Lundahl J. Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthma. Allergy 2002;54:323-8.
  13. Chopra S, Levell NJ, Cowley G, Gilkes JJH. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996;134:1109-12.
  14. Buyuktiryaki AB, Bezirganoglu H, Sahiner UM, Yavuz ST, Tuncer A, Kara A, et al. Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl. Australas J Dermatol. 2012 Nov;53(4):274-7. doi: 10.1111/j.1440-0960.2012.00887.x.Epub 2012 Apr 24. PMID: 22524313.
  15. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].  [Updated 2019 May 4].